Compound ID | 169
Class: Peptide-locked nucleic acid
| Spectrum of activity: | Gram-positive |
| Details of activity: | MRSA (methicillin resistant Staphylococcus aureus) |
| Institute where first reported: | Department of Pharmacology, School of Pharmacy, Fourth Military Medical University, Xi'an, China |
| Year first mentioned: | 2015 |
| Highest developmental phase: | Preclinical |
| Development status: | Active |
| External links: | |
| Citations: |
|